Global best practice recommendations for genetic counselling and testing in amyotrophic lateral sclerosis

Clicks: 15
ID: 337418
2026
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #406 of 455 articles by views in Brain research

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 455 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Abstract Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease with substantial clinical and genetic heterogeneity. Advances in ALS genomics, emerging gene-targeted therapies, and genotype-specific clinical trials have increased the importance of genetic counselling and testing for individuals with ALS and their families. However, access to these services remains highly variable globally due to disparities in healthcare infrastructure, laboratory capacity, specialist availability, and funding. Existing guidance has largely been developed in high-resource settings and may not be feasible or equitable worldwide. The International Alliance of ALS/MND Associations convened an international, multidisciplinary Genetics Task Force to develop expert consensus recommendations for genetic counselling, genetic testing, and laboratory practice in ALS across diverse geographic and resource settings. Recommendations were developed through a structured, iterative consensus process incorporating clinical expertise, lived experience perspectives, published evidence, and global representation. Final recommendations were reviewed and approved through anonymous voting at an in-person consensus meeting. The resulting recommendations establish both minimum and aspirational best practices, emphasizing equitable access, informed decision-making, culturally responsive counselling, tiered genetic testing approaches, and context-appropriate laboratory standards. These globally informed recommendations provide a pragmatic framework to support clinicians, laboratories, policymakers, and advocacy organizations in improving access to high-quality ALS genetics services worldwide.
Reference Key
openalex_W7223987693 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Kristiana Salmon, Martina de Majo, Nazli A. Basak, Ashley Crook, Cathy Cummings, Laynie Dratch, Marcondes C. França, Jeannine M. Heckmann, Paige Higgins, Daniel Knight, Albert Koo, Atchayaram Nalini, Guy Armand Rouleau, Nortina Shahrizaila, Dilraj Singh Sokhi, Bugyeong Son, Priya Treesa Thomas, Paula Trefiak, Philip Van Damme, Alliance Genetics Task Force Working Group Members, Azlina Ahmad‐Annuar, Maya Binet, Thos Cochrane, Kuldip D. Dave, Amy E. Easton, Sali Farhan, Gisella Gargiulo, Natalie Gauld, Jade Howard, Madina Kara, Adria Martig, Christopher J. McDermott, Alisdair McNeill, Agnes Nishimura, Amy Shea, Gethin Thomas, Giulia Valente, Jeff Vierstra, Bruce Virgo, Steve Vucic, Jennifer Roggenbuck, Matt Harms, Ammar Al‐Chalabi
Are you one of these authors? Claim your profile
Journal Brain research
Year 2026
DOI
10.1093/brain/awag375
URL
https://doi.org/10.1093/brain/awag375
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.